PRF1 and cancer: Upon cancer cell recognition, CAR T-cells act via multiple cytotoxic mechanisms, involving the release of perforins and granzymes, Fas ligand signaling, and secretion of inflammatory cytokines, such as the Tumor Necrosis Factor α (TNFα) and Interferon γ (IFNγ) [132].